{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:09:58Z","timestamp":1791331798825,"version":"4.3.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"abstract":"Summary<\/jats:title>\n \n Background and objectives<\/jats:title>\n Previous study revealed that complement activation products of the alternative pathway could be detected in renal specimens of human ANCA-associated vasculitis. The current study aimed to investigate the clinical and pathologic significance of complement activation products in the urine and kidneys of patients with ANCA-associated vasculitis.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n Renal biopsy specimens from 29 patients with ANCA-associated vasculitis diagnosed at Peking University First Hospital from January of 2008 to December of 2010 were randomly collected. Urine samples from 27 of 29 patients in active stage and 22 ANCA-associated vasculitis patients in complete remission who were independent of the above-mentioned 29 patients were collected. Urine samples from 28 patients with lupus nephritis and 25 healthy individuals were also collected. The renal deposition of Bb, C3d, and C5b-9 were detected by immunohistochemistry. The urinary levels of Bb, C3a, C5a, and soluble C5b-9 were determined by ELISA.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The deposition, measured by the mean optical density of Bb, which is an alternative complement pathway marker, in glomeruli correlated with the proportion of total crescents (\n r<\/jats:italic>\n =0.50,\n P<\/jats:italic>\n =0.006), the extent of interstitial infiltrate (\n r<\/jats:italic>\n =0.59,\n P<\/jats:italic>\n =0.001), interstitial fibrosis (\n r<\/jats:italic>\n =0.45,\n P<\/jats:italic>\n =0.01), and tubular atrophy (\n r<\/jats:italic>\n =0.55,\n P<\/jats:italic>\n =0.002), whereas it correlated inversely with the proportion of normal glomeruli (\n r<\/jats:italic>\n =\u22120.49,\n P<\/jats:italic>\n =0.008). The urinary levels of Bb, C3a, C5a, and soluble C5b-9 were all significantly higher in active compared with remission stage. The urinary levels of Bb in patients with active ANCA-associated vasculitis correlated with the serum creatinine (\n r<\/jats:italic>\n =0.56,\n P<\/jats:italic>\n =0.002) and correlated inversely with the proportion of normal glomeruli in renal specimens (\n r<\/jats:italic>\n =\u22120.49,\n P<\/jats:italic>\n =0.009).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The present study provides additional evidence that complement activation through the alternative pathway occurred in the development of ANCA-associated vasculitis. The renal deposition of Bb and urinary Bb levels were associated with the severity of renal injury.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.02790313","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T09:30:38Z","timestamp":1381483838000},"page":"1884-1891","source":"Crossref","is-referenced-by-count":161,"title":["Alternative Complement Pathway Activation Products in Urine and Kidneys of Patients with ANCA-Associated GN"],"prefix":"10.2215","volume":"8","author":[{"given":"Shen-Ju","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230811","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/ndt\/8.8.696","article-title":"IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA).","volume":"8","author":"Segelmark","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"R2-9-20230811","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1681\/ASN.V82314","article-title":"ANCA small-vessel vasculitis.","volume":"8","author":"Falk","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R3-9-20230811","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1797.2009.01086.x","article-title":"Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.","volume":"14","author":"Van Timmeren","year":"2009","journal-title":"Nephrology (Carlton"},{"key":"R4-9-20230811","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2119\/molmed.2010.00149","article-title":"New insights of an old defense system: Structure, function, and clinical relevance of the complement system.","volume":"17","author":"Ehrnthaller","year":"2011","journal-title":"Mol Med"},{"key":"R5-9-20230811","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11926-000-0042-6","article-title":"Laboratory testing in the evaluation and diagnosis of vasculitis.","volume":"2","author":"Cuellar","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"R6-9-20230811","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice.","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int"},{"key":"R7-9-20230811","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"R8-9-20230811","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R9-9-20230811","doi-asserted-by":"crossref","first-page":"e38317","DOI":"10.1371\/journal.pone.0038317","article-title":"p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.","volume":"7","author":"Hao","year":"2012","journal-title":"PLoS ONE"},{"key":"R10-9-20230811","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2012.10.041","article-title":"Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation.","volume":"54","author":"Hao","year":"2013","journal-title":"Mol Immunol"},{"key":"R12-9-20230811","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/ndt\/gfn586","article-title":"Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis.","volume":"24","author":"Chen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R13-9-20230811","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar3873","article-title":"C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.","volume":"14","author":"Yuan","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R14-9-20230811","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"key":"R15-9-20230811","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"R16-9-20230811","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis.","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R17-9-20230811","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference.","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R18-9-20230811","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited.","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R19-9-20230811","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R20-9-20230811","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/oxfordjournals.ndt.a027086","article-title":"The renal histopathology in systemic vasculitis: An international survey study of inter- and intra-observer agreement.","volume":"11","author":"Bajema","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R21-9-20230811","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1523-1755.1999.00758.x","article-title":"Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis.","volume":"56","author":"Bajema","year":"1999","journal-title":"Kidney Int"},{"key":"R22-9-20230811","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups.","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"R23-9-20230811","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-065X.2001.1800103.x","article-title":"Structure and biology of complement protein C3, a connecting link between innate and acquired immunity.","volume":"180","author":"Sahu","year":"2001","journal-title":"Immunol Rev"},{"key":"R24-9-20230811","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"R25-9-20230811","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.03896.x","article-title":"Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.","volume":"156","author":"Gullstrand","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R26-9-20230811","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.194.6.781","article-title":"C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.","volume":"194","author":"Ogden","year":"2001","journal-title":"J Exp Med"},{"key":"R27-9-20230811","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1681\/ASN.V891363","article-title":"The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.","volume":"8","author":"Morita","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R28-9-20230811","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1681\/ASN.V114700","article-title":"Complement activation products in the urine from proteinuric patients.","volume":"11","author":"Morita","year":"2000","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201311000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:43Z","timestamp":1786369423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201311000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02790313","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}